120 related articles for article (PubMed ID: 28588284)
1. A novel preventive strategy against HIV-1 infection: combinatorial use of inhibitors targeting the nucleocapsid and fusion proteins.
Yang Y; Zhu J; Hassink M; Jenkins LMM; Wan Y; Appella DH; Xu J; Appella E; Zhang X
Emerg Microbes Infect; 2017 Jun; 6(6):e40. PubMed ID: 28588284
[TBL] [Abstract][Full Text] [Related]
2. Human immunodeficiency virus type 1 nucleocapsid inhibitors impede trans infection in cellular and explant models and protect nonhuman primates from infection.
Wallace GS; Cheng-Mayer C; Schito ML; Fletcher P; Miller Jenkins LM; Hayashi R; Neurath AR; Appella E; Shattock RJ
J Virol; 2009 Sep; 83(18):9175-82. PubMed ID: 19587055
[TBL] [Abstract][Full Text] [Related]
3. Combinations of 3-hydroxyphthalic anhydride-modified ovalbumin with antiretroviral drug-based microbicide candidates display synergistic and complementary effects against HIV-1 infection.
Li L; Tan S; Lu H; Lu L; Yang J; Jin H; Liu S; Jiang S
J Acquir Immune Defic Syndr; 2011 Apr; 56(5):384-92. PubMed ID: 21239999
[TBL] [Abstract][Full Text] [Related]
4. The M-T hook structure increases the potency of HIV-1 fusion inhibitor sifuvirtide and overcomes drug resistance.
Chong H; Yao X; Qiu Z; Sun J; Qiao Y; Zhang M; Wang M; Cui S; He Y
J Antimicrob Chemother; 2014 Oct; 69(10):2759-69. PubMed ID: 24908047
[TBL] [Abstract][Full Text] [Related]
5. Preclinical evaluation of a mercaptobenzamide and its prodrug for NCp7-targeted inhibition of human immunodeficiency virus.
Hartman TL; Yang L; Helfrick AN; Hassink M; Shank NI; George Rosenker K; Scerba MT; Saha M; Hughes E; Wang AQ; Xu X; Gupta P; Buckheit RW; Appella DH
Antiviral Res; 2016 Oct; 134():216-225. PubMed ID: 27568924
[TBL] [Abstract][Full Text] [Related]
6. Preclinical evaluation of the HIV-1 fusion inhibitor L'644 as a potential candidate microbicide.
Harman S; Herrera C; Armanasco N; Nuttall J; Shattock RJ
Antimicrob Agents Chemother; 2012 May; 56(5):2347-56. PubMed ID: 22330930
[TBL] [Abstract][Full Text] [Related]
7. In vivo antiviral activity of novel human immunodeficiency virus type 1 nucleocapsid p7 zinc finger inhibitors in a transgenic murine model.
Schito ML; Goel A; Song Y; Inman JK; Fattah RJ; Rice WG; Turpin JA; Sher A; Appella E
AIDS Res Hum Retroviruses; 2003 Feb; 19(2):91-101. PubMed ID: 12639244
[TBL] [Abstract][Full Text] [Related]
8. Small-molecule inactivation of HIV-1 NCp7 by repetitive intracellular acyl transfer.
Miller Jenkins LM; Ott DE; Hayashi R; Coren LV; Wang D; Xu Q; Schito ML; Inman JK; Appella DH; Appella E
Nat Chem Biol; 2010 Dec; 6(12):887-9. PubMed ID: 20953192
[TBL] [Abstract][Full Text] [Related]
9. Colorectal microbicide design: triple combinations of reverse transcriptase inhibitors are optimal against HIV-1 in tissue explants.
Herrera C; Cranage M; McGowan I; Anton P; Shattock RJ
AIDS; 2011 Oct; 25(16):1971-9. PubMed ID: 21811139
[TBL] [Abstract][Full Text] [Related]
10. Rationally Designed Peptides as Efficient Inhibitors of Nucleic Acid Chaperone Activity of HIV-1 Nucleocapsid Protein.
Shvadchak V; Zgheib S; Basta B; Humbert N; Langedijk J; Morris MC; Ciaco S; Maskri O; Darlix JL; Mauffret O; Fossé P; Réal E; Mély Y
Biochemistry; 2018 Jul; 57(30):4562-4573. PubMed ID: 30019894
[TBL] [Abstract][Full Text] [Related]
11. Entry inhibitor-based microbicides are active in vitro against HIV-1 isolates from multiple genetic subtypes.
Ketas TJ; Schader SM; Zurita J; Teo E; Polonis V; Lu M; Klasse PJ; Moore JP
Virology; 2007 Aug; 364(2):431-40. PubMed ID: 17428517
[TBL] [Abstract][Full Text] [Related]
12. An Intravaginal Ring for the Simultaneous Delivery of an HIV-1 Maturation Inhibitor and Reverse-Transcriptase Inhibitor for Prophylaxis of HIV Transmission.
Ugaonkar SR; Clark JT; English LB; Johnson TJ; Buckheit KW; Bahde RJ; Appella DH; Buckheit RW; Kiser PF
J Pharm Sci; 2015 Oct; 104(10):3426-39. PubMed ID: 26149293
[TBL] [Abstract][Full Text] [Related]
13. Rapamycin reduces CCR5 density levels on CD4 T cells, and this effect results in potentiation of enfuvirtide (T-20) against R5 strains of human immunodeficiency virus type 1 in vitro.
Heredia A; Gilliam B; Latinovic O; Le N; Bamba D; Devico A; Melikyan GB; Gallo RC; Redfield RR
Antimicrob Agents Chemother; 2007 Jul; 51(7):2489-96. PubMed ID: 17485501
[TBL] [Abstract][Full Text] [Related]
14. Sifuvirtide, a potent HIV fusion inhibitor peptide.
Wang RR; Yang LM; Wang YH; Pang W; Tam SC; Tien P; Zheng YT
Biochem Biophys Res Commun; 2009 May; 382(3):540-4. PubMed ID: 19289098
[TBL] [Abstract][Full Text] [Related]
15. Design and Synthesis of DiselenoBisBenzamides (DISeBAs) as Nucleocapsid Protein 7 (NCp7) Inhibitors with anti-HIV Activity.
Sancineto L; Mariotti A; Bagnoli L; Marini F; Desantis J; Iraci N; Santi C; Pannecouque C; Tabarrini O
J Med Chem; 2015 Dec; 58(24):9601-14. PubMed ID: 26613134
[TBL] [Abstract][Full Text] [Related]
16. [The current progress in the development of HIV-1 fusion inhibitors].
Shi WG; Jia QY; Liu KL
Yao Xue Xue Bao; 2010 Feb; 45(2):184-93. PubMed ID: 21351428
[TBL] [Abstract][Full Text] [Related]
17. A Lipopeptide HIV-1/2 Fusion Inhibitor with Highly Potent
Chong H; Xue J; Xiong S; Cong Z; Ding X; Zhu Y; Liu Z; Chen T; Feng Y; He L; Guo Y; Wei Q; Zhou Y; Qin C; He Y
J Virol; 2017 Jun; 91(11):. PubMed ID: 28356533
[TBL] [Abstract][Full Text] [Related]
18. The Low-Cost Compound Lignosulfonic Acid (LA) Exhibits Broad-Spectrum Anti-HIV and Anti-HSV Activity and Has Potential for Microbicidal Applications.
Gordts SC; Férir G; D'huys T; Petrova MI; Lebeer S; Snoeck R; Andrei G; Schols D
PLoS One; 2015; 10(7):e0131219. PubMed ID: 26132818
[TBL] [Abstract][Full Text] [Related]
19. Baseline susceptibility of primary HIV-2 to entry inhibitors.
Borrego P; Calado R; Marcelino JM; Bártolo I; Rocha C; Cavaco-Silva P; Doroana M; Antunes F; Maltez F; Caixas U; Barroso H; Taveira N
Antivir Ther; 2012; 17(3):565-70. PubMed ID: 22293827
[TBL] [Abstract][Full Text] [Related]
20. Probing Mercaptobenzamides as HIV Inactivators via Nucleocapsid Protein 7.
Saha M; Scerba MT; Shank NI; Hartman TL; Buchholz CA; Buckheit RW; Durell SR; Appella DH
ChemMedChem; 2017 May; 12(10):714-721. PubMed ID: 28395128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
